Belgian researchers sought to determine which patients are appropriate candidates for tapering biologics. In this article, we summarize their findings.
1. Dierckx S, Lauwerys BR, Sokolova T, et al. Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost effective in daily clinical practice: DATA from the Brussels UCL RA Cohort [abstract]. Arthritis Rheumatol. 2018;70(suppl 10).